Factors associated with retention in a long-term residential rehabilitation programme for women with substance use problems

Mental Health and Substance Use: Dual Diagnosis

Volumn 2, Issue 1, 2009, Pages 40-51

  Johns, Kristy ^a   Baker, Amanda ^a   Webster, Rosemary A ^b   Lewin, Terry J ^a  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

Comorbidity; Heroin; Rehabilitation; Retention; Substance misuse; Treatment; Women

Indexed keywords

ALCOHOL; AMPHETAMINE DERIVATIVE; CANNABIS; DIAMORPHINE; OPIATE; TRANQUILIZER;

ADULT; ARTICLE; AUSTRALIA; DEMOGRAPHY; DISEASE DURATION; FEMALE; HUMAN; LENGTH OF STAY; LONG TERM CARE; MAJOR CLINICAL STUDY; PATIENT COMPLIANCE; PRIORITY JOURNAL; RESIDENTIAL CARE; SOCIAL ASPECT; SOCIAL INTERACTION; SOCIAL SUPPORT; SUBSTANCE ABUSE; TOBACCO; TREATMENT PLANNING;

EID: 67651210639     PISSN: 17523281     EISSN: 17523273     Source Type: Journal    
DOI: 10.1080/17523280802593285     Document Type: Article

References (36)

1. Bell, K., Crammer-Benjamin, D., & Anastas, J. (1997). Predicting length of stay in substance-using pregnant and postpartum women in day treatment. Journal of Substance Abuse Treatment, 14, 393-400.
2. Condelli, W.S. (1994). Predictors of retention in therapeutic communities. NIDA Research Monograph, 144, 117-127.
3. Condelli, W.S., & DeLeon, G. (1993). Fixed and dynamic predictors of client retention in therapeutic communities. Journal of Substance Abuse Treatment, 10, 11-16.
4. Copeland, J., & Hall, W. (1992a). A comparison of predictors of treatment drop-out women seeking drug and alcohol treatment in a specialist women's and two traditional mixed-sex treatment services. British Journal of Addiction, 87, 883-890.
5. Copeland, J., & Hall, W. (1992b). A comparison of women seeking drug and alcohol treatment in a specialist women's and two traditional mixed-set treatment services. British Journal of Addiction, 87, 1293-1302.
6. Copeland, J., Hall, W., Didcott, P., & Biggs, V. (1993). A comparison of a specialist women's alcohol and other drug treatment service with two traditional mixed-sex services: Client characteristics and treatment outcomes. Drug and Alcohol Dependence, 32, 81-92.
7. Corrigan, E.M. (1987). Women's combined use of alcohol and other mind-altering drugs. In D. Burden & N. Gottlieb (Eds.), The woman client (pp. 162-176). New York, NY: Tavistock.
8. Cosden, M., & Cortez-Ison, E. (1999). Sexual abuse, parental bonding, social support and programme retention for women in substance abuse treatment. Journal of Substance Abuse Treatment, 16, 149-155.
9. Darke, S., Hall, W., Wodak, A., Heather, N., & Ward, J. (1992). Development and validation of a multi-dimensional instrument for assessing outcome of treatment among opiate users: The Opiate Treatment Index. British Journal of Addiction, 87, 733-742.
10. Darke, S., Ross, J., & Teesson, M. (2007). The Australian Treatment Outcome Study (ATOS): What have we learnt about treatment for heroin dependence? Drug and Alcohol Review, 26, 49-54.
11. Darke, S., Williamson, A., Ross, J., & Teesson, M. (2006a). Reductions in heroin use are not associated with increases in other drug use: 2-year findings from the Australian Treatment Outcome Study. Drug and Alcohol Dependence, 84, 201-205.
12. Darke, S., Williamson, A., Ross, J., & Teesson, M. (2006b). Residential rehabilitation for the treatment of heroin dependence: Sustained heroin abstinence and drug-related problems 2 years after treatment entrance. Addictive Disorders and Their Treatment, 5, 9-18.
13. Degenhardt, L., Day, C., Gilmore, S., & Wayne, H. (2005). Patterns of illicit drug use in NSW, Australia following a reduction in heroin supply. International Journal of Drug Policy, 16,300-307.
14. DeLeon, G., & Schwartz, S. (1984). The therapeutic community: What are the retention rates? American Journal of Drug and Alcohol Abuse, 10, 267-284.
15. Gerada, C., Johns, K.J., Baker, A., & Castle, D. (2006). Substance use and abuse in women. In D.J. Castle, J. Kulkarni & K.M. Abel (Eds.), Mood and anxiety disorders in women (pp. 39-58). Cambridge: Cambridge University Press.
16. Goldberg, D.P., & Hillier, V.F. (1979). A scaled version of the General Health Questionnaire. Psychological Medicine, 9, 139-145.
17. Greenfield, S.F., Brooks, A.J., Gordon, S.M., Green, C.A., Kropp, F., McHugh, R.K., et al. (2007). Substance abuse treatment entry, retention, and outcome in women: A review of the literature. Drug and Alcohol Dependence, 86, 1-21.
18. Hughes, P.H., Coletti, S.D., Neri, R.L., Urmann, C.F., Stahl, S., Sicilian, D.M., et al. (1995). Retaining cocaine-abusing women in a therapeutic community: The effect of a child live-in programme. American Journal of Public Health, 85, 1149-1152.
19. Joe, G.W., & Simpson, D.D. (1975). Retention in treatment of drug users: 1971-1972 DARP admissions. The American Journal of Drug and Alcohol Abuse, 2, 63-71.
20. Knight, D.K., Hood, P.E., Logan, S.M., & Chatham, L.R. (1999). Residential treatment for women with dependent children: One agency's approach. Journal of Psychoactive Drugs, 31, 339-351.
21. Lex, B.W., Ellingboe, J.E., Teoh, S.K., Mendelson, J.H., & Rhoades, E. (1991). Prolactin and cortisol levels following acute alcohol challenges in women with and without a family history of alcoholism. Alcohol, 8, 383-387.
22. Maglione, M., Chao, B., & Anglin, M.D. (2000). Correlates of outpatient drug treatment drop-out among methamphetamine users. Journal of Psychoactive Drugs, 32, 221-228.
23. Marsh, J.C., D'Aunno, T.A., & Smith, B.D. (2000). Increasing access and providing social services to improve drug abuse treatment for women with children. Addiction, 95, 1237-1247.
24. National Institute on Drug Abuse. (1992). 20 Questions and answers about drug abuse treatment, DHHS Publication No. ADM 92-1951. Rockville, MD: US Department of Health and Human Services.
25. Niv, N., & Hser, Y.I. (2007). Women-only and mixed-gender drug abuse treatment programmes: Service needs, utilization and outcomes. Drug and Alcohol Dependence, 87, 194-201.
26. Romans-Clarkson, S.E., Walton, V.A., Herbison, G.P., & Mullen, P.E. (1989). Validity of the GHQ-28 in New Zealand women. Australian and New Zealand Journal of Psychiatry, 23, 187-196.
27. Ross, S., Dermatis, H., Levounis, P., & Galanter, M. (2003). A comparison between dually diagnosed inpatients with and without Axis II comorbidity and the relationship to treatment outcome. The American Journal of Drug and Alcohol Abuse, 29, 263-279.
28. Shand, F., & Mattick, R.P. (2001). Clients of treatment service agencies: May 2001 census findings. Canberra: Australian Government Publishing Service.
29. Sheffet, A.M., Quinones, M.A., Doyle, K.M., Lavenhar, M.A., El Nakar, A., et al. (1980). Assessment of treatment outcomes in a drug abuse rehabilitation network: Newark, New Jersey. The American Journal of Drug and Alcohol Abuse, 7, 141-173.
30. Simpson, D.D. (1979). The relation of time spent in drug abuse treatment to posttreatment outcome. The American Journal of Psychiatry, 136, 1449-1453.
31. Simpson, D.D. (1981). Treatment for drug abuse. Follow-up outcomes and length of time spent. Archives of General Psychiatry, 38, 875-880.
32. Simpson, D.D., Joe, G.W., Broome, K.M., Hiller, M.L., Knight, K., & Rowan-Szal, G.A. (1997). Programme diversity and treatment retention rates in the Drug Abuse Treatment Outcome Study (DATOS). Psychology of Addictive Behaviours, 11, 279-293.
33. Strantz, I., & Welch, S. (1995). Postpartum women in outpatient drug abuse treatment: Correlates of retention/completion. Journal of Psychoactive Drugs, 27, 357-373.
34. Szuster, R.R., Rich, L.L., Chung, A., & Bisconer, S.W. (1996). Treatment retention in women's residential chemical dependency treatment: The effect of admission with children. Substance Use and Misuse, 31, 1001-1013.
35. Weisner, C. (2005). Substance misuse: What place for women-only treatment programmes. Addiction, 100, 7-8.
36. Wobie, K.E., Fonda, D., Conlon, M., Clarke, L., & Behnke, M. (1997). Women and children in residential treatment: Outcomes for mothers and their infants. Journal of Drug Issues, 27, 585-606.